This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CHICAGO -- When AI in mammography is coupled with a safeguard radiologist review, women are more likely to pay for breast cancer screening mammography if the AI will boost exam results, research presented December 5 at the RSNA meeting suggests. The finding comes from a study of nearly 750,000 women who chose to enroll in a self-pay, AI-enhanced breast cancer screening program.
CHICAGO Philips brought a range of new AI-enhanced offerings to RSNA 2024 aimed at bolstering efficiency and improving workflows for radiologists and radiologic technologists. MRI In MRI, the star of the show was Philips next-generation of its 1.5-tesla BlueSeal MR wide-bore scanner. Available in two versions -- SE and UE -- the new scanner features a 70 cm design and integrated AI-enabled MR Smart Workflow software, the latter of which increases patient throughput without compromising diagnost
The system combines findings from SPECT myocardial perfusion imaging with lifestyle and clinical factors to predict risk of major cardiovascular events.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
There's plenty of research and technologies on display at RSNA 2024 when it comes to breast imaging. Just ask Amy Patel, MD, from Liberty Hospital in Missouri. Patel, who serves as medical director of the hospital's Breast Care Center, spoke with AuntMinnie.com about trends and technologies she has seen during her time in Chicago. She also talked about what breast imaging facilities can expect with the U.S.
In a multicenter study involving over 747,000 women who had mammography screening, those who paid for AI-enhanced screening had a 21 percent higher recall rate and a 15 percent higher positive predictive value (PPV) for breast cancer, according to research presented at the Radiological Society of North America (RSNA) conference.
In a multicenter study involving over 747,000 women who had mammography screening, those who paid for AI-enhanced screening had a 21 percent higher recall rate and a 15 percent higher positive predictive value (PPV) for breast cancer, according to research presented at the Radiological Society of North America (RSNA) conference.
CHICAGO A new version of its 3-tesla MRI scanner, AI technologies, and CT technology improvements were among the highlights for CanonMedical Systems at RSNA 2024. MRI In MRI, Canon gave Vantage Galan 3T / Supreme Edition its RSNA debut. Introduced in April, the new release, for the first time, features all components that have been manufactured by Canon.
In a recent interview, Sarah Friedewald, MD, discussed new study findings for an adjunctive AI software for digital breast tomosynthesis (DBT) that revealed nearly equivalent sensitivity and specificity rates for breast cancer across a diverse cohort.
CHICAGO -- In a wide-ranging interview, Saurabh Jha, MD, discusses topics such as his recent trip to Nepal, the controversy over whole-body MRI screening, and how radiologists can handle the recent presidential election results in the U.S. For full 2024 RSNA coverage, visit our RADCast.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
A new risk score based on SPECT imaging and other variables can accurately predict risks for women of major adverse cardiovascular events, according to a December 5 study published in Radiology: Cardiothoracic Imaging. The new risk score fills a significant gap in efforts to improve cardiac care in women, noted lead author Guillermo Romero-Farina, MD, PhD, of the Vall dHebron University Hospital in Barcelona, Spain, and colleagues.
A study has found that incorporating late gadolinium enhancement into existing risk models can more accurately predict the risk of sudden cardiac death in children with hypertrophic cardiomyopathy.
AI chatbots such as Gemini and ChatGPT-4 have considerable potential to answer common patient questions about theranostics treatments, yet struggle with the complexity of the topic, according to a December 4 presentation at RSNA. Specifically, researchers asked the chatbots 12 questions about lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617 treatment and while they provided easy-to-understand answers, this came at the expense of accuracy, noted presenter Gokce Belge Bilgin, MD
Medical Device Regulation ensures safety, enhances standards, fosters innovation, and supports effective healthcare delivery. The post Racing Against the Clock: Reigniting Europes Medtech Marketplace appeared first on Open MedScience.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Use of a convolutional neural network (CNN) trained with photon-counting CT (PCCT) data improves the image resolution of coronary CT angiography (CTA) exams, according to research presented December 1 at the RSNA meeting. "[Our CNN] enhanced image resolution and reduced image noise, resulting in improved overall image quality and reduced calcium blooming artifacts in coronary CTA exams performed using EID [energy-integrating detectors]-CT," presenter Emily Koons told session attendees.
Digital therapeutics provide innovative solutions for managing diseases, improving care accessibility, and supporting personalised treatments. The post Transforming Care: How Digital Tools Reshape Diagnostics and Treatment appeared first on Open MedScience.
Cleerly has raised $106 million in a Series C extension funding round. The company said it will use the investments for commercial growth and clinical evidence generation around its AI-enabled CT technologies that have been cleared by the U.S. Food and Drug Administration (FDA). Cleerlys software is designed to identify heart disease by analyzing noninvasive images.
Wearable devices and apps empower individuals to monitor health, support telemedicine, and enhance personalised healthcare management. The post Wearable Devices and Apps: A Growing Partnership appeared first on Open MedScience.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
CHICAGO -- Educational initiatives may be needed to address misconceptions about radiology among medical students and highlight the fields attractiveness as a career for graduates, a study presented December 4 at RSNA 2024 found. In her presentation, Magdalena Seng, MD, from University Hospital Basel in Switzerlandshowed survey findings indicating that while medical students recognize radiologys importance, many are not interested in pursuing a career as radiologists.
A new study has shown how AI can be applied to CT scans—initially performed to detect tumors, bleeding, or infections—to also reveal calcium buildup in arteries.
Israel-based Nano-X Imaging (Nanox) has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for the Nanox.ARC, an x-ray system incorporating advanced tomosynthesis technology to produce tomographic images for general use on adults. These images may include the musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications.
Weight loss medications are transforming healthcare, challenging medical devices, reshaping obesity treatment, and redefining patient outcomes globally. The post Weight Loss Medications Transform Healthcare Medical Device Giants appeared first on Open MedScience.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
The Society of Interventional Radiology (SIR) has selected Eve Lee as its new CEO. Lee previously was the executive director of the American Orthotic and Prosthetic Association (AOPA). She also served as executive director of the Society for Healthcare Epidemiology of America (HEA). The SIR said that Lee will join the society in late January 2025.
Focused ultrasound developer Arrayus Technologies is promoting the completion of focused ultrasound treatment for breast cancer at Sunnybrook Health Sciences Centre in Toronto by 30 patients participating in a phase I prospective clinical trial using the companys focused ultrasound platform. The trial, led by Gregory Czarnota, MD, is evaluating the safety and potential of the Arrayus device to enhance tumor response to external beam radiation therapy.
We all know the benefits of patient-specific planning, but how do we make it more accessible? Solutions across medtech are breaking down the barriers every step of the way. ✅ Scan CurveBeam AI’s systems allow for clinic-based 3D imaging, and in weight bearing as a bonus. ✅ Plan Formus’ automated platform provides surgeons with 3D pre-operativer plans in less than an hour. ✅ Surgery Intellijoint’s imageless surgical navigation platform has set standards in intraoperative guidanc
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content